好想你健康食品股份有限公司 好想你健康食品股份有限公司 董事会 2025 年 4 月 22 日 董事会关于独立董事独立性自查情况的专项意见 根据《上市公司独立董事管理办法》《深圳证券交易所股票上市规则》《深圳 证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等要求， 结合独立董事出具的《独立董事独立性自查表》，好想你健康食品股份有限公司 （以下简称"公司"）董事会，就公司在任独立董事廖小军先生、张建君先生、 许晓芳女士的独立性情况进行评估并出具如下专项意见： 经核查独立董事廖小军先生、张建君先生、许晓芳女士的任职经历以及签署 的相关自查文件，上述人员未在公司担任除独立董事以外的任何职务，也未在公 司主要股东公司担任任何职务，与公司以及主要股东之间不存在利害关系或其他 可能妨碍其进行独立客观判断的关系，公司独立董事符合《上市公司独立董事管 理办法》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范 运作》中对独立董事独立性的相关要求。 ...

好想你健康食品股份有限公司 2024 年度，本人作为好想你健康食品股份有限公司（以下简称"公司"）的 独立董事，严格按照《公司法》、《上市公司独立董事管理办法》、《深圳证券交易 所上市公司自律监管指引第 1 号——主板上市公司规范运作》等相关法律法规以 及《公司章程》、《独立董事工作制度》的规定，忠实、勤勉地履行独立董事职责， 有效维护了公司和股东尤其是中小股东的合法权益。现将本人 2024 年度履职情 况报告如下： 一、本人基本情况 （独立董事：廖小军） 本人廖小军，出生于 1966 年，中国国籍，无境外居留权，博士。学科方向： 农产品加工及贮藏工程。曾任北京市永定门食品厂研发部经理/工程师、中国农 业大学食品科学与营养工程学院讲师、副教授、副院长；现任中国农业大学食品 科学与营养工程学院教授、院长。 本人符合《上市公司独立董事管理办法》中对独立董事独立性的相关要求， 不存在影响独立性的情况。 二、本人年度履职概况 （一）出席董事会、股东大会情况 2024 年度，公司共召开 7 次董事会和 3 次股东大会，本人作为公司独立董 事均亲自以通讯方式出席。本着对公司和股东负责的态度，本人在会前认真审阅 会议材料， ...

好想你健康食品股份有限公司 本人张建君，出生于 1967 年，中国国籍，无境外居留权，中共党员，博士。 研究领域：组织理论，企业社会责任，企业政治行为，企业文化。曾任人民日报 社记者、北京大学光华管理学院讲师、副教授；现任北京大学光华管理学院组织 与战略管理系教授、系主任，北京大学管理案例研究中心副主任。 本人符合《上市公司独立董事管理办法》中对独立董事独立性的相关要求， 不存在影响独立性的情况。 二、本人年度履职概况 （一）出席董事会、股东大会情况 2024 年度，公司共召开 7 次董事会和 3 次股东大会，本人作为公司独立董 事均亲自以通讯方式出席。本着对公司和股东负责的态度，本人在会前认真审阅 会议材料，会上认真审议各项议案，积极参与讨论，提出合理化建议，并以谨慎 的态度行使表决权。基于谨慎性原则，本人对第五届董事会第二十二次会议审议 的《关于第六届董事会董事薪酬或津贴方案的议案》进行了回避表决，对董事会 审议的其他 61 项议案均投了赞成票。 2024 年度独立董事述职报告 （独立董事：张建君） 2024 年度，本人作为好想你健康食品股份有限公司（以下简称"公司"）的 独立董事，严格按照《公司法》、《 ...

好想你健康食品股份有限公司 2024 年度独立董事述职报告 （独立董事：许晓芳） 2024 年度，本人作为好想你健康食品股份有限公司（以下简称"公司"）的 独立董事，严格按照《公司法》、《上市公司独立董事管理办法》、《深圳证券交易 所上市公司自律监管指引第 1 号——主板上市公司规范运作》等相关法律法规以 及《公司章程》、《独立董事工作制度》的规定，忠实、勤勉地履行独立董事职责， 有效维护了公司和股东尤其是中小股东的合法权益。现将本人 2024 年度履职情 况报告如下： 一、本人基本情况 本人许晓芳，出生于 1986 年，中国国籍，无境外居留权，中共党员，博士 研究生学历，教授，博士生导师。主要从事公司治理、资本市场会计与财务、信 息披露等教学与科研工作。曾于华东交通大学、铜陵学院任教，2021 年 4 月至 今，任北京工商大学商学院教授、博士生导师。 本人符合《上市公司独立董事管理办法》中对独立董事独立性的相关要求， 不存在影响独立性的情况。 二、本人年度履职概况 （一）出席董事会、股东大会情况 2024 年度，公司共召开 7 次董事会和 3 次股东大会，本人作为公司独立董 事均亲自以通讯方式出席。本着对公 ...

Financial Performance - The company's revenue for Q1 2025 was ¥412,675,749.66, a decrease of 16.44% compared to ¥493,842,037.29 in the same period last year[4] - Net profit attributable to shareholders increased by 216.08% to ¥39,806,100.77 from ¥12,593,798.52 year-on-year[4] - Basic and diluted earnings per share both improved to ¥0.09, up 200% from ¥0.03 in the same period last year[4] - Total operating revenue decreased to ¥412,675,749.66 from ¥493,842,037.29, representing a decline of approximately 16.4% year-over-year[19] - Net profit increased to ¥39,679,441.45 from ¥12,108,646.46, marking a significant increase of approximately 227.5% year-over-year[20] - Earnings per share increased to ¥0.09 from ¥0.03, reflecting a growth of 200% year-over-year[21] Cash Flow - The net cash flow from operating activities reached ¥66,077,525.50, representing a significant increase of 167.39% compared to ¥24,712,434.57 in the previous year[4] - The net cash flow from financing activities was ¥119,154,040.85, a turnaround from a negative cash flow of ¥102,953,352.70 in the previous year[9] - Operating cash flow net amount improved to ¥66,077,525.50 from ¥24,712,434.57, an increase of about 167.5% year-over-year[23] - Investment activities generated a net cash flow of -¥63,764,754.12, compared to a positive cash flow of ¥290,868,255.23 in the previous period[23] - Financing activities generated a net cash flow of ¥119,154,040.85, compared to a negative cash flow of -¥102,953,352.70 in the previous period[23] Assets and Liabilities - Total assets at the end of the reporting period were ¥4,977,529,136.37, reflecting a 1.77% increase from ¥4,890,765,768.80 at the end of the previous year[4] - Total current assets amounted to ¥2,145,048,163.67, up from ¥2,048,198,769.52, indicating an increase of about 4.73%[15] - The total liabilities decreased from ¥964,542,627.41 to ¥722,392,177.34, a reduction of approximately 25.14%[16] - Total liabilities increased to ¥1,410,309,848.89 from ¥1,363,374,295.09, an increase of approximately 3.4%[18] - Total equity attributable to shareholders rose to ¥3,599,329,461.92 from ¥3,559,523,361.15, an increase of about 1.1%[18] Shareholder Information - The total number of common shareholders at the end of the reporting period is 82,244[11] - The largest shareholder, Shi Jubin, holds 28.61% of the shares, totaling 129,289,218 shares, with 15,000,000 shares pledged[11] - The number of shares held by the company's repurchase account was 15,666,404, accounting for 3.47% of total shares[12] Inventory and Costs - The company’s inventory decreased from ¥370,982,986.34 to ¥315,477,726.97, a decline of about 15%[15] - Total operating costs decreased to ¥394,558,906.52 from ¥493,502,734.36, a reduction of about 20.1% year-over-year[19] Other Financial Metrics - The company reported a significant increase in fair value gains of 233.38%, amounting to ¥11,124,933.54 compared to a loss of ¥8,340,546.44 in the previous year[9] - The company’s income tax expense increased significantly by 969.76% to ¥4,936,596.97, driven by higher profits during the period[9] - Long-term borrowings surged by 163.84% to ¥467,000,000.00 from ¥177,000,000.00, indicating increased financing activities[9] - Long-term borrowings increased significantly from ¥177,000,000.00 to ¥467,000,000.00, reflecting a growth of 164.48%[16] - The company reported a significant increase in investment income to ¥14,649,096.98 from ¥14,459,637.60, a growth of approximately 1.3% year-over-year[20] Capital Changes - The company plans to reduce its registered capital by repurchasing and canceling 305,000 restricted shares, decreasing the registered capital from ¥452,259,369 to ¥451,954,369[12] Cash and Cash Equivalents - The company's cash and cash equivalents increased to ¥1,044,808,068.48 from ¥916,576,041.16, representing a growth of approximately 13.95%[14] - The net increase in cash and cash equivalents for the period was $121,466,812.23, compared to $212,627,337.10 in the previous period[24] - The beginning balance of cash and cash equivalents was $148,285,797.61, down from $388,342,726.88 in the prior period[24] - The ending balance of cash and cash equivalents stood at $269,752,609.84, compared to $600,970,063.98 previously[24] Governance and Compliance - The first quarter report was not audited[25] - The new accounting standards will be implemented starting in 2025[25] - The board of directors of the company convened on April 24, 2025[26]

Financial Performance - The company's operating revenue for 2024 was CNY 1,669,658,260.11, a decrease of 3.39% compared to CNY 1,728,222,464.78 in 2023[21] - The net profit attributable to shareholders for 2024 was a loss of CNY 71,957,710.58, representing a 38.67% increase in losses compared to a loss of CNY 51,891,864.74 in 2023[21] - The net cash flow from operating activities decreased by 79.93% to CNY 86,766,670.96 in 2024 from CNY 432,231,272.53 in 2023[21] - The basic earnings per share for 2024 was -CNY 0.16, a decline of 33.33% from -CNY 0.12 in 2023[21] - Total assets at the end of 2024 were CNY 4,890,765,768.80, down 13.00% from CNY 5,621,588,574.71 at the end of 2023[21] - The net assets attributable to shareholders decreased by 13.80% to CNY 3,559,523,361.15 at the end of 2024 from CNY 4,129,477,408.02 at the end of 2023[21] - The company reported a significant decrease in net profit after deducting non-recurring gains and losses, with a net profit of -CNY 80,515,115.74 for 2024 compared to -CNY 59,329,870.71 in 2023, a decline of 35.71%[21] - The company's total revenue for Q1 was approximately CNY 493.84 million, while Q2 and Q3 revenues were CNY 322.57 million and CNY 361.08 million, respectively, with Q4 revenue at CNY 492.17 million[26] - The net profit attributable to shareholders for Q1 was CNY 12.59 million, but the company reported losses in Q2 (CNY -48.83 million), Q3 (CNY -24.47 million), and Q4 (CNY -11.25 million)[26] Revenue Sources and Trends - Revenue from the food industry was ¥1,566,492,289.07, accounting for 93.82% of total revenue, down 2.92% year-over-year[71] - Sales of red date products reached ¥1,221,631,005.97, representing 73.17% of total revenue, a decline of 6.83% from the previous year[71] - E-commerce revenue decreased by 16.38% to ¥474,745,075.88, down from ¥567,766,894.70 in 2023[71] - The company’s gross profit margin for the food industry was 22.51%, a decrease of 3.36% compared to the previous year[74] - The total sales volume in the food industry was 36,480.43 tons, down 7.55% from 39,461.49 tons in 2023[75] - Inventory levels increased by 66.10% to 4,033.53 tons, compared to 2,428.37 tons in the previous year[75] Product Development and Innovation - The company has launched multiple health food products based on traditional medicinal ingredients, enhancing its product diversification[37] - The company launched 126 new products during the reporting period, confirming 47 formulations, including an upgraded version of the skinless jujube kernel pie[61] - The company introduced 12 new health-preserving fresh-keeping products, including red date rose silver ear soup and five red porridge, expanding its market presence[62] - The company aims to leverage the unique qualities of jujubes to develop health-oriented snacks, aligning with consumer trends towards nutritious food[35] - The company is expected to enhance its supply chain and marketing strategies to ensure competitive pricing and product quality in response to changing consumer preferences[34] Market Position and Strategy - The company has established itself as the leading enterprise in the Chinese jujube industry, contributing significantly to the sector over the past 30 years[36] - The international market potential for jujubes is significant, with increasing demand from global consumers for high-quality products[35] - The company is positioned in the agricultural and food processing industry, focusing on the development, production, and sales of health food products, particularly jujube-based items[30] - Recent government policies support innovation and high-quality development in the food industry, which may enhance the company's growth prospects[31] - The food industry is shifting towards health-oriented and functional products, indicating a growing market for the company's offerings[33] Financial Management and Investments - The company plans to distribute a cash dividend of CNY 10 per 10 shares to all shareholders[5] - The company’s total investment during the reporting period was ¥828,003,671.35, a decrease of 38.43% compared to ¥1,344,739,098.04 in the same period last year[98] - The company has plans for market expansion and new product development in the health food sector, targeting increased consumer demand[167] - The company is exploring potential acquisitions to enhance its product portfolio, with a budget of $100 million allocated for this purpose[133] - The company plans to repurchase shares as part of its capital management strategy[173] Governance and Compliance - The company has a comprehensive governance structure that complies with relevant laws and regulations[139] - The company emphasizes information disclosure, ensuring timely and accurate communication with all shareholders[145] - The company has established a dedicated risk management department to oversee derivative trading and ensure compliance with internal policies and procedures[105] - The company is focusing on improving its corporate governance and compliance following recent disciplinary actions from regulatory bodies[167] - The board of directors consists of 9 members, including 3 independent directors, and operates through four specialized committees[142] Employee and Management Structure - The company has a total of 575 production personnel, 987 sales personnel, 73 technical personnel, 76 financial personnel, and 107 administrative personnel[183] - The company has established a layered and position-based compensation system that links employee salaries to performance and job value[184] - The company has implemented a structured talent strategy, fostering a diverse talent pool across different generations[57] - The company has a strong management team with diverse backgrounds, including expertise in finance, law, and food science, enhancing its operational capabilities[155][156][157] - The company has seen the departure of several senior management personnel due to term completion in December 2024[152] Risk Management - The company faces risks from raw material price fluctuations, particularly in agricultural products, and has implemented measures such as establishing production bases and utilizing futures markets to stabilize costs[124] - The company plans to continue its focus on risk management through hedging strategies to mitigate price volatility in raw materials[101] - The company’s financial derivatives investment is aimed at stabilizing procurement costs and enhancing overall profitability, contributing positively to operational performance[101] Shareholder Engagement - The company has conducted 2 extraordinary and 1 annual shareholder meetings during the reporting period[140] - The annual shareholders' meeting in 2023 had a participation rate of 39.31%[148] - The first extraordinary shareholders' meeting in 2024 had a participation rate of 38.65%[148] - The second extraordinary shareholders' meeting in 2024 had a participation rate of 34.01%[148] - The company is committed to fulfilling its social responsibilities and balancing the interests of stakeholders[144]

关于完成工商变更登记手续并换发营业执照的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 《好想你健康食品股份有限公司营业执照》 证券代码：002582 证券简称：好想你 公告编号：2025-011 好想你健康食品股份有限公司 好想你健康食品股份有限公司（以下简称"公司"）于 2024 年 12 月 26 日召 开第六届董事会第一次会议，并于 2025 年 1 月 13 日召开 2025 年第一次临时股 东大会审议通过了《关于减少注册资本及修订<公司章程>的议案》，具体内容详 见 2024 年 12 月 27 日 和 2025 年 1 月 14 日 披露于巨潮资讯网 （http://www.cninfo.com.cn）的相关公告。 近日，公司已完成 2023 年限制性股票激励计划 305,000 股限制性股票回购 注销减资相关事项的工商变更登记及《公司章程》备案手续，并取得新郑市市场 监督管理局换发的《营业执照》。现将具体情况公告如下： 一、本次工商登记变更的主要事项 | 序号 | 变更项目 | 变更前内容 | | 变更后内容 | | --- | --- ...

证券代码：002582 证券简称：好想你 公告编号：2025-010 好想你健康食品股份有限公司 关于控股股东部分股份质押及解除质押的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 好想你健康食品股份有限公司（以下简称"公司"或"本公司"）于近日接 到控股股东石聚彬先生通知，获悉其持有本公司的部分股份办理了质押及解除质 押业务，现将有关事项公告如下： | | 是否为控 股股东或 | 本次 质押 | 占其所 | 占公 | 是否为 限售股 | 是否 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股东名 | | | | 司总 | （如 | 为补 | 质押 | 质押 | | 质押用 | | 称 | 第一大股 | 数量 | 持股份 | 股本 | 是，注 | 充质 | 起始日 | 到期日 | 质权人 | 途 | | | 东及其一 | （股 | 比例 | 比例 | 明限售 | 押 | | | | | | | 致行动人 | ） | | | 类型） | | | ...

好想你健康食品股份有限公司 关于控股股东部分股份质押及解除质押的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 好想你健康食品股份有限公司（以下简称"公司"或"本公司"）于近日接 到控股股东石聚彬先生通知，获悉其持有本公司的部分股份办理了质押及解除质 押业务，现将有关事项公告如下： | | 是否为控 | 本次 | | 占公 | 是否为 限售股 | 是否 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股东名 | 股股东或 | 质押 | 占其所 | 司总 | （如 | 为补 | 质押 | 质押 | | 质押用 | | 称 | 第一大股 | 数量 | 持股份 | 股本 | 是，注 | 充质 | 起始日 | 到期日 | 质权人 | 途 | | | 东及其一 | （股 | 比例 | 比例 | 明限售 | 押 | | | | | | | 致行动人 | ） | | | 类型） | | | | | | | 石聚彬 | 是 | | | | | | | | | ...